Sebia
Hazelle Lam is an experienced professional in the fields of sales and marketing, currently serving as General Manager for SEA & APAC Export Area at Sebia since January 2020. Previously, Hazelle held various leadership roles including Director of Sales and Marketing and Business Consultant at Veredus Laboratories from August 2010 to January 2020, and Sales Director for Asia at Fluidigm Corp from March 2008 to August 2010. Additional experience includes positions as Marketing Manager for Asia at Pall Life Sciences, Product Manager for Southeast Asia at Bio-Rad Laboratories, and Sales Manager and Sales Representative at Research Instruments Pte Ltd. Hazelle holds an MBA from the University of Adelaide and a Diploma in Biotechnology, along with a Management Diploma in International Business from Ngee Ann Polytechnic.
This person is not in any teams
This person is not in any offices
Sebia
2 followers
Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable and interpretable language. We call it our new language of life. The “language of life” makes it easier to understand, diagnose and treat chronic and metabolic diseases produced by the modern way of life. Cancer, obesity, aging and depression share a common biology: they are metabolic and inflammatory. Those pathological imbalances lead to protein modification which require special separation techniques to give us a better understanding. Capillary Electrophoresis (CE) is the most accurate and efficient method of separation to unlock these complex conditions. Sebia is a Global specialized In Vitro Diagnostic player and the world’s leading provider of clinical protein electrophoresis equipment and reagents for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy and other rare pathologies. Headquartered in the South of Paris (Lisses, France), We set high standards in making continuous advances in CE technology, scientific excellence and manufacturing capabilities, providing Sebia the possibility to pursue diagnostic solutions with an exciting pipeline of new tests and automated equipment.